Monitoring the progression of metastatic breast cancer on nanoporous silica chips
Open Access
- 28 May 2012
- journal article
- research article
- Published by The Royal Society in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
- Vol. 370 (1967) , 2433-2447
Abstract
Breast cancer accounted for 15 per cent of total cancer deaths in female patients in 2010. Although significant progress has been made in treating early-stage breast cancer patients, there is still no effective therapy targeting late-stage metastatic breast cancers except for the conventional chemotherapy interventions. Until effective therapy for later-stage cancers emerges, the identification of biomarkers for the early detection of tumour metastasis continues to hold the key to successful management of breast cancer therapy. Our study concentrated on the low molecular weight (LMW) region of the serum protein and the information it contains for identifying biomarkers that could reflect the ongoing physiological state of all tissues. Owing to technical difficulties in harvesting LMW species, studying these proteins/peptides has been challenging until now. In our study, we have recently developed nanoporous chip-based technologies to separate small proteins/peptides from the large proteins in serum. We used nanoporous silica chips, with a highly periodic nanostructure and uniform pore size distribution, to isolate LMW proteins and peptides from the serum of nude mice with MDA-MB-231 human breast cancer lung metastasis. By matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and biostatistical analysis, we were able to identify protein signatures unique to different stages of cancer development. The approach and results reported in this study possess a significant potential for the discovery of proteomic biomarkers that may significantly enhance personalized medicine targeted at metastatic breast cancer.Keywords
This publication has 29 references indexed in Scilit:
- Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chipBiomicrofluidics, 2011
- Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteinsNanoscale, 2010
- Nanotexture optimization by oxygen plasma of mesoporous silica thin film for enrichment of low molecular weight peptides captured from human serumScience China Chemistry, 2010
- Triple-negative breast cancer: disease entity or title of convenience?Nature Reviews Clinical Oncology, 2010
- Detection of minimal residual disease in blood and bone marrow in early stage breast cancerCancer, 2010
- Nanodevices in diagnosticsWIREs Nanomedicine and Nanobiotechnology, 2010
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?JNCI: Journal of the National Cancer Institute, 2010
- Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteomeProteomics, 2010
- Tailoring of the Nanotexture of Mesoporous Silica Films and Their Functionalized Derivatives for Selectively Harvesting Low Molecular Weight ProteinACS Nano, 2009
- Current two‐dimensional electrophoresis technology for proteomicsProteomics, 2004